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EDITORIALZooming in on Inﬂammatory Bowel Disease: Microbial
and Proteomic Features Associated With IBD in
Colonic Microenvironmentsnﬂammatory bowel disease (IBD) is a multifactorialIchronic intestinal inﬂammatory disorder character-
ized both by genetic and environmental factors.1 Among the
latter, the microbiome recently emerged as one of the most
promising avenues of research to understand the patho-
genesis of IBD. Several studies have shown differences in
microbiome composition and diversity in IBD patients
compared with healthy controls.2,3 Larger cohorts have
allowed for further characterization of the gut microbiota in
IBD patients, including assays that determine function and
activity of the microbiome and thus provide better mecha-
nistic insights.4–6 Most of these studies, however, investi-
gated microbial composition in stool or in the colonic
mucosal surface, missing potentially important factors
hidden in deeper layers of the colon. Furthermore, we still
lack a good understanding of how the microbiome interacts
with the host at the proteomic level. The September issue of
Cellular and Molecular Gastroenterology and Hepatology
presents 2 new exciting articles that highlight the impor-
tance of in situ microbiome structure in deep colonic layers
and metaproteomic functional networks in the character-
ization of IBD.
Pedamallu et al7 analyzed the microbiome structure in
deep layers of the ileum obtained from Crohn’s disease
(CD) patients and compared it with IBD-free controls who
had undergone surgery for right-sided colon cancer. The
authors distinguished involved (diseased) and uninvolved
areas using microscopy in samples from CD patients.
Although CD patients and controls differed in bacterial
composition at the phylum level (with a signiﬁcant
depletion of Bacteroidetes in patients), no such differences
were observed between involved and uninvolved regions
in the ﬁrst group. It is possible, however, that some of the
observed differences were caused by the administration of
metronidazole and levoﬂoxacin to CD patients during the
course of the disease. Direct comparison of involved and
uninvolved areas in patients found a statistically nonsig-
niﬁcant, but intriguing, enrichment of Staphylococcus and
Delftia in the former. Interestingly, a Staphylococcus aureus
pathogenicity island was detected in involved tissue from
2 patients, suggesting that enterotoxigenic strains could be
partially responsible for localization of lesions in CD.
Comparison of involved and IBD-free tissue also showed
enrichment in Mycobacterium species in disease, particu-
larly Mycobacterium abscessus.
Li et al8 used metaproteomics (the set of host and
microbial proteins found in a given environment) to
characterize the mucosal–luminal interface in CD andCellular and Molecular Gastroenterology and Hepatology 2016;2:540–5ulcerative colitis (UC) patients compared with healthy
subjects. The authors collected mucosal lavages at 6
colonic regions from IBD and non-IBD subjects, and found
that roughly one third of the proteins in the lavages were
of bacterial origin, with nearly half of those being pro-
duced by Bacteroidetes. Primary component analysis
identiﬁed intersubject variability as the major contributor
to variance (57.5%) of the metaproteome, followed by
disease (21.5%), and colonic region (15%). By using cor-
relation network analysis, the authors identiﬁed mucosal
protein modules with different functional activity and
cellular origin. Three of these modules were linked to the
colon, but 6 were related to disease. Further character-
ization of these modules identiﬁed some of their member
proteins, among which several were associated with dis-
ease. These included a-defensins such as human neutrophil
peptide (increased in UC and CD), hepcidin and transferrin
(enriched in UC patients), or human b–defensins (increased
in CD). Bioinformatic analysis, immunoblotting, and
immunohistochemical assays also suggested the spatial
localization of different protein patterns as distributed in
a microgeographic mosaic, with scales ranging from mi-
crons to millimeters. The authors thus hypothesized that
the mucosal surface is heterogeneous, and consists of local
mucosal functional networks with speciﬁc regions enriched
in metabolic activities that provide a habitat for host re-
sponses contributing to disease states.
These results present compelling evidence of the
nonhomogeneous nature of the intestinal mucosa and of
how different regions of the colon harbor microenviron-
ments colonized by different bacterial species that could
determine disease state. The interaction of localized
microbial communities and the host through speciﬁc pro-
teomic networks can induce host responses that determine
disease course, suggesting potential targets for therapeutic
interventions. Given the high intersubject variability
observed, future studies would beneﬁt from longitudinal
sampling in which each subject could serve as his or her
own control, thereby improving power to detect features
directly associated with disease or location. The low
biomass of tissue samples is also an important technical
hurdle in microbiome studies,9 and standardized methods
that improve their handling and processing would be a
major advance. Improved methods for selectively enriching
bacterial DNA and protein while reducing human contami-
nation also will be critical tools as we improve our under-
standing of how microbes and microbial products
contribute to IBD pathogenesis.41
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